查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494837

感染疾病诊断的全球市场：分析 - 按产品、按疾病、按技术、按最终用户、按地区、预测（至 2030 年）

Infectious Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Disease, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

全球感染疾病诊断市场规模预计到2024年将达到236.3亿美元，到2030年将达到427.8亿美元，预测期内复合年增长率为10.4%。

感染疾病诊断是指识别人体内是否有细菌、病毒、真菌、寄生虫等病原体，以诊断感染疾病的过程。这些诊断使用各种旨在检测特定病原体及其标记物的技术和方法，通常透过分析体液、组织或其他样本。快速诊断测试 (RDT) 也可用于在资源有限的环境中进行快速识别。准确及时诊断感染疾病对于有效的患者管理、开始适当的治疗、实施感染控制措施和疾病监测至关重要。

根据美国疾病管制与预防美国(CDC) 的数据，2018 年，美国医院每年报告约 170 万人感染疾病和 99,000 人相关死亡。据美国食品药物管理局（FDA）称，2020年，每年约有30万名50岁以上的人被诊断出患有肺炎球菌肺炎。

对就地检验的需求不断增长

就地检验提供了一种快速、方便和分散式检查解决方案，可在患者床边或社区环境中快速诊断并及时做出治疗决策。这种向 POCT 的转变是由多种因素推动的，包括快速週转时间的需要，特别是在感染疾病爆发和像 COVID-19 这样的大流行期间。此外，POCT 减轻了集中检测设施和医疗基础设施的负担，使服务不足的人口和偏远地区更容易进行检测。

诊断测试成本高

诊断测试的高成本是感染疾病诊断市场成长的主要障碍。这些成本包括测试开发、製造和分销等各个方面，所有这些成本都会影响支付给患者和医疗保健系统的最终价格。对于许多患者，尤其是低收入和中等收入国家的患者来说，这些费用令人望而却步，并导致诊断和后续治疗的延迟或漏诊。然而，高昂的费用使医疗保健预算紧张，并限制了获得基本诊断服务的机会。

公众健康意识不断增强

公众健康意识的提高对感染疾病诊断市场的成长做出了重大贡献。随着人们对早期发现和预防感染疾病重要性的认识不断加深，个人和政府正在诊断技术上投入更多资源。像 COVID-19 大流行这样的全球健康危机凸显了诊断测试在遏制疫情和指导公共卫生应对方面所发挥的关键作用。这导致人们专注于快速、准确和具有成本效益的诊断解决方案的开发和实施，促进感染疾病诊断市场的创新，并促进医疗保健专业人员、研发机构和诊断公司之间的合作。

诊断程序的复杂性

诊断程序的复杂性是感染疾病诊断市场成长的主要障碍。这些复杂性包括许多方面，例如测试方法所涉及的技术复杂性、获得结果所需的时间长度以及需要熟练的人员准确地执行和解释测试。然而，传染源的多样性及其不断演变的性质进一步使诊断通讯协定变得复杂，并且需要不断更新和调整检测技术。这种复杂性不仅增加了医疗保健系统的成本负担，而且阻碍了感染疾病的及时有效的诊断和治疗。

COVID-19 的影响：

COVID-19 大流行对感染疾病诊断市场产生了重大影响。对检测病毒的诊断测试的需求前所未有地激增，导致市场迅速扩张。这次大流行凸显了诊断测试在控制感染疾病的重要性，并导致对新诊断技术研发的投资增加。然而，疫情扰乱了供应链和分销网络，导致检测套组和试剂暂时短缺。

预计在预测期内，真菌感染疾病领域将是最大的。

由于侵袭性真菌疾病的流行，尤其是在免疫力缺乏中，真菌感染疾病预计将在预测期内成为感染疾病诊断市场中最大的部分。意识的提高、诊断技术的进步以及及时准确识别真菌病原体的需求正在推动市场成长。医院感染发生率的增加、与真菌感染相关的高发病率和死亡率进一步促进了这一领域的扩大。

次世代定序领域预计在预测期内将经历最高的复合年增长率

由于次世代定序能够快速、全面地分析病原体的遗传物质，预计该领域将在预测期内实现最高的复合年增长率。该技术允许在一次测试中同时检测和表征多种感染原，包括细菌、病毒、真菌和寄生虫。透过对病原体的整个基因组或特定区域进行定序，NGS 可以提供对其遗传多样性、抗药性特征和流行病学模式的宝贵见解。这种综合方法提高了感染疾病诊断的准确性和效率，特别是当传统方法可能无法识别致病微生物或区分密切相关的菌株时。此外，NGS有助于即时检测新兴感染疾病和监测疫情，使医疗保健专业人员能够及时实施有针对性的干预措施，以更好地管理和控制疾病。

比最大的地区

在整个估计期间，亚太地区占据了最大的市场份额。随着人口老化，由于免疫力减弱和其他与老龄化相关的因素，他们自然更容易受到感染疾病。这些人口变化增加了对诊断工具和服务的需求，以有效检测和管理老年人的感染疾病。此外，都市化、生活方式的改变和医疗保健设施的改善等因素也促进了该地区感染疾病诊断市场的扩张。

复合年增长率最高的地区：

预计欧洲地区在预测期内将保持盈利成长。透过欧盟体外诊断法规 (IVDR) 等严格的法规结构，当局保证诊断测试的品质、安全性和有效性。这些法规不仅为产品开发和製造设定了高标准，而且有利于创新诊断技术的及时核准和市场准入。此外，遵守这些法规可以增强医疗保健专业人员和患者之间的信任，从而促进先进诊断解决方案的区域采用。

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第四章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球感染疾病诊断市场：副产品

  • 测定/试剂
  • 套件
  • 消耗品
  • 装置
  • 软体服务

第六章全球感染疾病诊断市场：依疾病分类

  • 细菌感染疾病
  • 病毒感染疾病
  • 霉菌感染疾病
  • 寄生虫感染疾病
  • 其他感染疾病

第七章全球感染疾病诊断市场：依技术分类

  • 免疫诊断
  • 微生物学
  • 聚合酵素链锁反应
  • 次世代定序
  • 其他技术

第八章全球感染疾病诊断市场：依最终用户分类

  • 诊断实验室
  • 学术研究所
  • 医院
  • 其他最终用户

第九章全球感染疾病诊断市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Bio-Rad Laboratories, Inc
  • Hologic, Inc
  • Luminex Corporation
  • Abbott Laboratories
  • GenMark Diagnostics, Inc
  • PerkinElmer, Inc
  • Thermo Fisher Scientific Inc
  • Bruker Corporation
  • Sysmex Corporation
  • Nanosphere Health Sciences Inc
  • Trinity Biotech plc
  • InBios International, Inc
  • Meridian Bioscience, Inc
Product Code: SMRC26354

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is expected to reach $42.78 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Infectious disease diagnostics refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a person's body to diagnose infectious diseases. These diagnostics involve various techniques and methods aimed at detecting specific pathogens or their markers, often through analyzing bodily fluids, tissues, or other samples. Rapid diagnostic tests (RDTs) are also utilized for quick identification in settings with limited resources. Accurate and timely diagnosis of infectious diseases is crucial for effective patient management, initiation of appropriate treatment, implementation of infection control measures, and disease surveillance.

According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.

Market Dynamics:

Driver:

Growing demand for point-of-care testing

Point-of-care testing offers rapid, convenient, and decentralized testing solutions, allowing for quick diagnosis and timely treatment decisions at the patient's bedside or in community settings. This shift towards POCT is driven by several factors, including the need for faster turnaround times, especially in infectious disease outbreaks or pandemics like COVID-19. Additionally, POCT reduces the burden on centralized laboratory facilities and healthcare infrastructure, making testing more accessible to underserved populations and remote areas.

Restraint:

High cost of diagnostic tests

The high cost of diagnostic tests poses a significant barrier to the growth of the Infectious Disease Diagnostics Market. These costs encompass various aspects such as test development, manufacturing, and distribution, all of which contribute to the final price borne by patients and healthcare systems. For many individuals, especially in low- and middle-income countries, these expenses are prohibitive, leading to delayed or missed diagnoses and subsequent treatment. However, high costs can strain healthcare budgets, limiting access to essential diagnostic services.

Opportunity:

Rise in public health awareness

The rise in public health awareness has substantially contributed to the growth of the Infectious Disease Diagnostics Market. With an increasing understanding of the importance of early detection and prevention of infectious diseases, individuals and governments alike are investing more resources into diagnostic technologies. The global health crises, such as the COVID-19 pandemic, have highlighted the critical role of diagnostic testing in containing outbreaks and guiding public health responses. Consequently, there is a growing emphasis on the development and adoption of rapid, accurate, and cost-effective diagnostic solutions, driving innovation in the infectious disease diagnostics market and fostering collaborations between healthcare providers, research institutions and diagnostic companies.

Threat:

Complexity of diagnostic procedures

The complexity of diagnostic procedures poses a significant obstacle in the growth of the Infectious Disease Diagnostics Market. These complexities encompass various facets, including the technical intricacies involved in testing methodologies, lengthy turnaround times for obtaining results, and the requirement for skilled personnel to perform and interpret tests accurately. However, the diversity of infectious agents and their evolving nature further complicates diagnostic protocols, necessitating continuous updates and adaptations to detection techniques. These complexities not only increase the cost burden on healthcare systems but also impede timely and effective diagnosis and treatment of infectious diseases.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the infectious disease diagnostics market. There was an unprecedented surge in demand for diagnostic tests to detect the virus, leading to a rapid expansion of the market. The pandemic highlighted the importance of diagnostic testing in controlling infectious diseases, leading to increased investment in research and development for novel diagnostic technologies. However, the pandemic also disrupted supply chains and distribution networks, causing temporary shortages of testing kits and reagents.

The Fungal Infections segment is expected to be the largest during the forecast period

The fungal infections segment is anticipated to be the largest in the infectious disease diagnostics market during the forecast period due to the rising prevalence of invasive fungal diseases, particularly among immunocompromised individuals. Increased awareness, advancements in diagnostic technologies, and the need for timely and accurate identification of fungal pathogens drive market growth. The growing incidence of hospital-acquired infections and the high morbidity and mortality rates associated with fungal infections further contribute to the segment's expansion.

The Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period

Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period by enabling rapid and comprehensive analysis of pathogens' genetic material. This technology allows for the simultaneous detection and characterization of multiple infectious agents, including bacteria, viruses, fungi, and parasites, in a single test. By sequencing the entire genome or specific regions of pathogens, NGS can provide valuable insights into their genetic diversity, drug resistance profiles, and epidemiological patterns. This comprehensive approach enhances the accuracy and efficiency of infectious disease diagnosis, particularly in cases where traditional methods may fail to identify the causative agent or distinguish between closely related strains. Additionally, NGS facilitates the detection of emerging infectious diseases and the monitoring of outbreaks in real-time, empowering healthcare professionals to implement timely and targeted interventions for better disease management and control.

Region with largest share:

Asia Pacific region commanded the largest share of the market throughout the extrapolated period. As populations age, there's a natural increase in susceptibility to infectious diseases due to weakened immune systems and other age-related factors. This demographic shift creates a higher demand for diagnostic tools and services to effectively detect and manage infectious diseases among the elderly. Additionally, factors such as urbanization, changing lifestyles, and increased access to healthcare facilities further contribute to the expansion of the infectious disease diagnostics market in the region.

Region with highest CAGR:

Europe region is poised to hold profitable growth during the projection period. Through stringent regulatory frameworks, such as the European Union's In Vitro Diagnostic Regulation (IVDR), authorities ensure the quality, safety, and efficacy of diagnostic tests. These regulations not only set high standards for product development and manufacturing but also facilitate timely approvals and market access for innovative diagnostic technologies. Moreover, compliance with these regulations fosters trust among healthcare professionals and patients, thereby driving the regional adoption of advanced diagnostic solutions.

Key players in the market

Some of the key players in Infectious Disease Diagnostics market include Bio-Rad Laboratories, Inc, Hologic, Inc, Luminex Corporation, Abbott Laboratories, GenMark Diagnostics, Inc, PerkinElmer, Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Sysmex Corporation, Nanosphere Health Sciences Inc, Trinity Biotech plc, InBios International, Inc and Meridian Bioscience, Inc.

Key Developments:

In February 2023, Abbott to acquire Cardiovascular Systems for $837.6 mln. The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.

In May 2022, Quidel Corporation a US-based company that provides rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, has acquired Ortho Clinical Diagnostics and the succeeding business groups.

Products Covered:

  • Assays & Reagents
  • Kits
  • Consumables
  • Instruments
  • Software & Services

Diseases Covered:

  • Bacterial Infections
  • Viral Infections
  • Fungal Infections
  • Parasitic Infections
  • Other Diseases

Technologies Covered:

  • Immunodiagnostics
  • Microbiology
  • Polymerase Chain Reaction
  • Next-generation Sequencing
  • Other Technologies

End Users Covered:

  • Diagnostic Laboratories
  • Academic Research Institutes
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Assays & Reagents
  • 5.3 Kits
  • 5.4 Consumables
  • 5.5 Instruments
  • 5.6 Software & Services

6 Global Infectious Disease Diagnostics Market, By Disease

  • 6.1 Introduction
  • 6.2 Bacterial Infections
  • 6.3 Viral Infections
  • 6.4 Fungal Infections
  • 6.5 Parasitic Infections
  • 6.6 Other Infectious Diseases

7 Global Infectious Disease Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Immunodiagnostics
  • 7.3 Microbiology
  • 7.4 Polymerase Chain Reaction
  • 7.5 Next-generation Sequencing
  • 7.6 Other Technologies

8 Global Infectious Disease Diagnostics Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Laboratories
  • 8.3 Academic Research Institutes
  • 8.4 Hospitals
  • 8.5 Other End Users

9 Global Infectious Disease Diagnostics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Bio-Rad Laboratories, Inc
  • 11.2 Hologic, Inc
  • 11.3 Luminex Corporation
  • 11.4 Abbott Laboratories
  • 11.5 GenMark Diagnostics, Inc
  • 11.6 PerkinElmer, Inc
  • 11.7 Thermo Fisher Scientific Inc
  • 11.8 Bruker Corporation
  • 11.9 Sysmex Corporation
  • 11.10 Nanosphere Health Sciences Inc
  • 11.11 Trinity Biotech plc
  • 11.12 InBios International, Inc
  • 11.13 Meridian Bioscience, Inc

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 25 North America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 26 North America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 27 North America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 28 North America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 29 North America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 30 North America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 31 North America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 32 North America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 33 North America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 34 North America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 35 North America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 36 North America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 37 North America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 38 North America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 39 North America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 40 North America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 41 North America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 42 North America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 43 North America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 44 North America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 45 North America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 46 North America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 47 North America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 48 North America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 49 Europe Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Europe Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 51 Europe Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 52 Europe Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 53 Europe Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 54 Europe Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 55 Europe Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 56 Europe Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 57 Europe Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 58 Europe Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 59 Europe Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 60 Europe Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 61 Europe Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 62 Europe Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 63 Europe Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 64 Europe Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 65 Europe Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 66 Europe Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 67 Europe Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 68 Europe Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 69 Europe Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 70 Europe Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 71 Europe Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 72 Europe Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 73 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 74 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 75 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 76 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 77 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 78 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 79 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 80 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 81 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 82 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 83 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 84 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 85 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 86 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 87 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 88 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 89 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 90 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 91 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 92 Asia Pacific Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 93 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 94 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 95 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 96 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 97 South America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 98 South America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 99 South America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 100 South America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 101 South America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 102 South America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 103 South America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 104 South America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 105 South America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 106 South America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 107 South America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 108 South America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 109 South America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 110 South America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 111 South America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 112 South America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 113 South America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 114 South America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 115 South America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 116 South America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 117 South America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 118 South America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 119 South America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 120 South America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 121 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 122 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 123 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 124 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 125 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 126 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 127 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 128 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 129 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 130 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 131 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 132 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 133 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 134 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 135 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 136 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 137 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 138 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 139 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 140 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 141 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 142 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 143 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 144 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)